Up a level |
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Docobo-Perez, Fernando, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Gastine, Silke, Dona, Ruwanthi Kolamunnage, de Costa, Renata MA et al (show 8 more authors)
(2021)
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Antimicrobial Agents and Chemotherapy, 65 (7).
e0029321-.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, McEntee, Laura, Johnson, Adam, Farrington, Nicola, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Jagota, Bhavana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally et al (show 6 more authors)
(2022)
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (12).
pp. 3349-3357.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Parrott, Neil, Peck, Richard W ORCID: 0000-0003-1018-9655 and Hope, William ORCID: 0000-0001-6187-878X
(2023)
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainment.
CPT: pharmacometrics & systems pharmacology, 13 (3).
pp. 464-475.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally, Franceschi, Francois et al (show 5 more authors)
(2022)
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (5).
pp. 1334-1343.
Darlow, Christopher A ORCID: 0000-0002-5400-3413 and Hope, William ORCID: 0000-0001-6187-878X
(2021)
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (3).
pp. 711-718.
Darlow, Christopher A ORCID: 0000-0002-5400-3413 and Hope, William ORCID: 0000-0001-6187-878X
(2022)
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales (vol 77, pg 711, 2022).
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (7).
p. 2049.
Darlow, Christopher A ORCID: 0000-0002-5400-3413 and Hope, William ORCID: 0000-0001-6187-878X
(2022)
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (7).
pp. 2047-2048.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, McGlashan, Nicholas, Kerr, Richard, Oakley, Sarah, Pretorius, Pieter, Jones, Nicola and Matthews, Philippa C
(2020)
Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius.
JOURNAL OF INFECTION, 80 (6).
pp. 623-629.
Farrington, Nicola ORCID: 0000-0003-2300-9430, Dubey, Vineet, Johnson, Adam, Horner, Iona, Stevenson, Adam, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Schwartz, Julie, Das, Shampa ORCID: 0000-0002-2540-4816, Hope, William ORCID: 0000-0001-6187-878X et al (show 1 more authors)
(2024)
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.
mBio, 15 (2).
e0316523-.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, da Costa, Renata MA, Ellis, Sally, Franceschi, Francois, Sharland, Mike, Piddock, Laura, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X
(2021)
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
PEDIATRIC DRUGS, 23 (5).
pp. 465-484.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Paidakakos, Nikolaos, Sikander, Murtuza and Atkins, Bridget
(2017)
A spinal infection with <i>Staphylococcus pseudintermedius</i>.
BMJ case reports, 2017.
bcr-2017-221260-.